No increased risk of lung infections among infants using popular anti-reflux medicines
Tuesday, 18 September 2018 10:16am
New University of Otago research shows infants using popular anti-reflux medicines like omeprazole are not at increased risk of pneumonia or other lower respiratory tract infections, contrary to findings from other international studies.
PhD candidate receives award
Thursday, 31 May 2018 12:07pm
Sarah Donald has received a prize in the 2018 Dunedin School of Medicine postgraduate poster competition for a poster which outlines the process of generating a pregnancy cohort for medicine utilisation and safety studies in New Zealand.
Prescribing guidelines not always followed for patients on cholesterol-lowering drug
Friday, 4 May 2018 10:40am
New Zealand prescribers do not always follow guidelines when prescribing other medicines to patients taking simvastatin, according to University of Otago researchers from the Pharmacoepidemiology Research Network.
Chronic lung disease treatment in New Zealand often not consistent with international guidelines
Tuesday, 19 December 2017 10:53am
University of Otago researchers have found that the treatment of chronic obstructive pulmonary disease (COPD) in New Zealand frequently does not conform to international guidelines.
No evidence higher doses of cholesterol-lowering drug increase risk of acute kidney damage
Monday, 31 July 2017 3:37pm
New Zealanders taking a higher dose of simvastatin, one of the cholesterol-lowering statin drugs used to prevent heart attacks and strokes, do not appear to have a higher risk of acute kidney damage than those taking a lower dose, according to University of Otago researchers from the Pharmacoepidemiology Research Network.
Researchers funded to investigate possible adverse effect of a common lung disease treatment
Thursday, 15 June 2017 9:23am
The University of Otago’s Dr Lianne Parkin and colleagues will receive a Health Research Council grant to investigate whether particular drugs used to treat a common lung disease put people at greater risk of heart attacks.
Off-label prescription of proton pump inhibitors to New Zealand infants is common
Thursday, 4 May 2017 12:09pm
Off-label use of proton pump inhibitors is common among New Zealand infants, according to new University of Otago research.
Otago researchers receive new joint pharmaceuticals research funding
Thursday, 2 March 2017 4:32pm
Researchers from University of Otago are among the first recipients of two new grants from PHARMAC and the Health Research Council of New Zealand (HRC).
Disparities in insulin pump use by New Zealanders with type 1 diabetes: Otago research
Friday, 23 September 2016 11:32am
There are significant demographic and regional disparities in the use of insulin pumps in New Zealand, according to new University of Otago research.
